Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2012
05/18/2012CA2815916A1 Combination of bevacizumab and 2,2-dimethyl-n-((s)-6-oxo-6,7-dihydro - 5h-dibenzo[b,d]azepin-7-yl)-n'-(2,2,3,3,3-pentafluoro-propyl)-malonamide for the treatment of proliferativedisorders
05/18/2012CA2815840A1 Methods and compositions for neural disease immunotherapy
05/18/2012CA2815689A1 Improved high concentration anti-tnf.alpha. antibody liquid formulations
05/18/2012CA2815492A1 Use of 2-carboxamide cycloamino urea derivatives in the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
05/18/2012CA2811113A1 Skin permeating and cell entering (space) peptides and methods of use thereof
05/17/2012US20120123093 Novel surface antigen
05/17/2012US20120122238 VMP-Like Sequences of Pathogenic Borrelia
05/17/2012US20120122206 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
05/17/2012US20120122185 Chimeric viruses presenting non-native surface proteins and uses thereof
05/17/2012US20120121715 DNA Vaccine Comprising IL-6-Encoding DNA Construct and Applications Thereof
05/17/2012US20120121714 Compositions with antigens adsorbed to calcium phosphate
05/17/2012US20120121713 Chimeric therapeutics, compositions, and methods for using same
05/17/2012US20120121710 Mucosal Immunization
05/17/2012US20120121701 Pharmaceutical composition of peptide drug and enzyme-inhibition compounds
05/17/2012US20120121690 Method to enhance an immune response of nucleic acid vaccination
05/17/2012US20120121688 Preventative or therapeutic agent and method for immune disease
05/17/2012US20120121656 Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
05/17/2012US20120121649 Compositions and methods for the prevention and treatment of cancer
05/17/2012US20120121648 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
05/17/2012US20120121647 Influenza vaccine, composition, and methods of use
05/17/2012US20120121646 Vaccine
05/17/2012US20120121645 Supralingual vaccines and applicators
05/17/2012US20120121644 Sticky soft gel for treating poultry
05/17/2012US20120121641 Mhc oligomer and method of making the same
05/17/2012US20120121639 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
05/17/2012US20120121638 Polypeptide Derived From Enterococcus And Its Use For Vaccination
05/17/2012US20120121637 Chimeric factor h binding proteins (fhbp) and methods of use
05/17/2012US20120121636 Tat-Based Vaccine Compositions and Methods of Making and Using Same
05/17/2012US20120121635 Expression in plants of HIV-related proteins
05/17/2012US20120121634 Soluble pd-1 variants, fusion constructs, and uses thereof
05/17/2012US20120121633 Hiv cd4 binding site based covalent immunogen compositions
05/17/2012US20120121632 TAT Protein for preventing or treating AIDS
05/17/2012US20120121631 Polyvalent vaccine
05/17/2012US20120121630 Recombinant ectodomain expression of herpes simplex virus glycoproteins in yeast
05/17/2012US20120121629 New human rotavirus vaccine strains and diagnostics
05/17/2012US20120121628 Lipidated polyepitope vaccines
05/17/2012US20120121627 Peptides for active anti-cytokine immunization
05/17/2012US20120121626 Chimeric VEGF Peptides
05/17/2012US20120121625 Peptide
05/17/2012US20120121624 Hepatitis c virus ns3 protease inhibitors
05/17/2012US20120121623 Novel antipathogenic peptides
05/17/2012US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof
05/17/2012US20120121621 Synergistic prebiotic compositions
05/17/2012US20120121620 Anti-estrogen and immune modulator combinations for treating breast cancer
05/17/2012US20120121616 Immune balance-regulating agent
05/17/2012US20120121615 Alaninyl maytansinol antibody conjugates
05/17/2012US20120121614 Methods and compositions for bi-specific targeting of cd19/cd22
05/17/2012US20120121612 Fermented wheat germ proteins (fwgp) for the treatment of cancer
05/17/2012US20120121611 Method of treating autoimmune disease with mesenchymal stem cells
05/17/2012US20120121610 Therapeutic agent and assay
05/17/2012US20120121609 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
05/17/2012US20120121608 Use of sam68 for modulating signaling through the tnf receptor
05/17/2012US20120121607 Antibodies to clostridium difficile toxins
05/17/2012US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/17/2012US20120121605 Anti sulfatides and anti sufated proteoglycans antibodies and their use
05/17/2012US20120121604 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
05/17/2012US20120121603 Compositions And Methods For The Therapy And Diagnosis Of Influenza
05/17/2012US20120121602 Novel proteins
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121600 Pharmaceutical antibody compositions with resistance to soluble cea
05/17/2012US20120121598 Compositions containing antibodies for treating cd5+hla-dr+b or t cell related diseases
05/17/2012US20120121597 Fusion proteins for hiv therapy
05/17/2012US20120121596 Bispecific anti-her antibodies
05/17/2012US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
05/17/2012US20120121594 Anti-il-6 antibodies for the treatment of arthritis
05/17/2012US20120121593 Method for determining predisposition to pulmonary infection
05/17/2012US20120121592 Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121590 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)
05/17/2012US20120121589 Modified egfr ectodomain
05/17/2012US20120121588 Modulation of pilr receptors to treat sepsis
05/17/2012US20120121587 Anti-axl antibody
05/17/2012US20120121586 Modulators for her2 signaling in her2 expressing patients with gastric cancer
05/17/2012US20120121585 SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121583 Antibodies against human tweak and uses thereof
05/17/2012US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease
05/17/2012US20120121581 Anti-Botulism Antibody Coformulations
05/17/2012US20120121580 Methods for producing high concentration lyophilized pharmaceutical formulations
05/17/2012US20120121579 Treatment of oncostatin m receptor beta mediated heart failure
05/17/2012US20120121578 Methods of using immunoglobulin aggregates
05/17/2012US20120121577 Antibodies as t cell receptor mimics, methods of production and uses thereof
05/17/2012US20120121576 Actriia binding agents and uses thereof
05/17/2012US20120121575 Prohibitin as target for cancer therapy
05/17/2012US20120121574 Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore
05/17/2012US20120121539 Programming Of Cells for Tolerogenic Therapies
05/17/2012US20120121538 Combined measles-malaria vaccine
05/17/2012US20120121536 Compositions and methods for glucose transport inhibition
05/17/2012US20120121512 Monoclonal antibodies and their use
05/17/2012US20120121506 Targeting of Bone Marrow Neovasculature
05/17/2012US20120121505 Therapeutic compositions and methods
05/17/2012US20120121504 B cell surface reactive antibodies
05/17/2012US20120121503 Inhibition Of CD69 For Treatment Of Inflammatory Conditions
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/17/2012US20120121501 Hmgn2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
05/16/2012EP2452950A1 Antibody having anti-cancer activity
05/16/2012EP2452948A1 New tumor marker
05/16/2012EP2452694A1 Anti-IL-23 antibodies, compositions, methods and uses
05/16/2012EP2452693A2 Vaccines and methods to treat canine influenza
05/16/2012EP2452675A1 Buccal spray containing sildenafil
1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 1823